Publication of Groundbreaking Study on Ultra-Sensitive Molecular Residual Disease Detection in EMBO Molecular Medicine
August 20, 2024
Latest News
AccuraGen Highlights New Developments in MRD Detection with AccuScan Whole-Genome Sequencing Solution
September 6, 2024
AccuraGen was invited to PMWC to showcase the latest achievements in liquid biopsy
January 29, 2018
Publication of Groundbreaking Study on Ultra-Sensitive Molecular Residual Disease Detection in EMBO Molecular Medicine
August 20, 2024
The study showed 90% sensitivity and 100% specificity in colorectal cancer patient blood samples collected within six weeks after surgery.
AccuraGen Highlights New Developments in MRD Detection with AccuScan Whole-Genome Sequencing Solution
September 6, 2024
AccuraGen is gaining attention in the medical community for its innovative approach to minimal residual disease (MRD) detection.
Collaborator Presented New Data at ESMO 2019 Congress
October 9, 2019
Dr. Tao Fu presented new data as a poster at the ESMO 2019 Congress.
